Hap Trading, LLC Deciphera Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$9.11 - $13.98 $6,377 - $9,786	-700 Reduced 2.99%	22,700 $12,000
Q1 2022 May 12, 2022	SELL	$6.87 - $11.11 $21,297 - $34,441	-3,100 Reduced 11.7%	23,400 $23,000
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $204,050 - $983,945	26,500 New	26,500 $27,000
Q3 2020 Nov 13, 2020	SELL	$43.8 - $58.16 $4.43 Million - $5.89 Million	-101,200 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$37.05 - $65.03 $14,819 - $26,012	400 Added 0.4%	101,200 $23,000
Q1 2020 May 08, 2020	BUY	$33.63 - $69.4 $2.71 Million - $5.59 Million	80,500 Added 396.55%	100,800 $14,000
Q4 2019 Feb 11, 2020	BUY	$31.7 - $69.93 $9,510 - $20,979	300 Added 1.5%	20,300 $550,000
Q3 2019 Nov 12, 2019	BUY	$19.95 - $38.85 $399,000 - $777,000	20,000 New	20,000 $89,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.